INVESTIGATION OF THE INTRAOPERATIVE AND POSTOPERATIVE EFFECTS OF EXTERNAL OBLIQUE INTERCOSTAL PLAN BLOCK IN PATIENTS UNDERGOING LAPARASCOPIC CHOLESYSTECTOMY OPERATION
- Conditions
- Laparoscopic Cholecystectomy
- Interventions
- Procedure: External Oblique Intercostal Plane BlockDrug: control group
- Registration Number
- NCT06712498
- Lead Sponsor
- Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
- Brief Summary
Objective: Regional anesthesia techniques, such as peripheral nerve blocks, have a lower side effect profile and higher patient satisfaction compared to central blocks. With the introduction of Ultrasonography (USG), these techniques have become more commonly and reliably performed. The purpose of our study is to compare parameters such as intraoperative hemodynamics, postoperative analgesic requirement, and patient satisfaction between patients undergoing External Oblique Intercostal Plane Block (EOIB) with those who did not receive EOIB, which has few studies conducted on it.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 64
- Patients aged between 18-65
- and with ASA1-2 were included.
• Patients younger than 18 years of age and older than 65 years of age
- Patients allergic to local anesthetics
- Patients with opioid and alcohol addiction
- Patients with perioperative signs of acute cholecystitis
- Patients with contraindications for laparoscopic surgery
- Cases with ASA III-IV were not included in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description External oblique intercostal plan block group External Oblique Intercostal Plane Block After endotracheal intubation, a 22-gauge 100 mm long block needle will be inserted at the T6-T7 level under USG guidance and bilateral EOIB will be applied with 20 cc of 0.25% Bupivacaine on each side under the external oblique intercostal muscle (total 40ml bilaterally). control group control group No Intervention
- Primary Outcome Measures
Name Time Method Numeric Rating Scale Postoperative 30.second,2 hours, 6 hours,12 hours,24 hours They will be numbered from 1 to 10. If reporting a score on a scale, please include the unabbreviated scale title, the minimum and maximum values, and whether higher scores mean a better or worse outcome
Visual Analogue Scale Postoperative 30.second,2 hours, 6 hours,12 hours,24 hours The Visual Analogue Scale (VAS) is a subjective measure of pain. It consists of a 10cm line with two endpoints representing 'no pain' and 'worst pain imaginable'. Patients are asked to rate their pain by placing a mark on the line corresponding to their current level of pain. The distance along the line from the 'no pain' marker is then measured with a ruler giving a pain score out of 10.
- Secondary Outcome Measures
Name Time Method Riker Sedation Agitation Scale Immediately after extubation 7 Dangerous Agitation ... If reporting a score on a scale, please include the unabbreviated scale title, the minimum and maximum values, and whether higher scores mean a better or worse outcome.
Patient satisfaction score at the 24th postoperative hour Patients' satisfaction with the quality of pain management will be evaluated on the second postoperative day using the following scale: 1 = very unsatisfied; 2 = highly dissatisfied; 3 = medium; 4 = very satisfactory; 5 = very satisfactory
Postoperative vomiting and nausea Postoperative 30.second,2 hours, 6 hours,12 hours,24 hours Postoperative vomiting and nausea: yes or no
Opioid use Postoperative 24 hours Tramadol use
Mean Arter Pressure when you come to the operating room table, after block Intraoperative 10 minutes,30 minutes postoperative 2,6,12 hours mm/hg
Heart Rate when you come to the operating room table, after block Intraoperative 10 minutes,30 minutes postoperative 2,6,12 hours beats/minute
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Health Sciences University Gazi Yaşargil Training and Research Hospital
🇹🇷Diyarbakır, Kayapınar, Turkey